Understanding how SARS-CoV-2 affects individuals with Down syndrome and heart defects
Dissecting SARS-CoV-2 infection in Down syndrome with congenital heart defects using patient-specific iPSCs
['FUNDING_R21'] · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · NIH-10698064
This study is looking at why people with Down syndrome and heart defects might be more at risk for severe COVID-19, using special cells to better understand how their bodies respond to the virus, which could help create better treatments and prevention strategies just for them.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | RESEARCH INST NATIONWIDE CHILDREN'S HOSP (nih funded) |
| Locations | 1 site (COLUMBUS, UNITED STATES) |
| Trial ID | NIH-10698064 on ClinicalTrials.gov |
What this research studies
This research investigates the unique vulnerabilities of individuals with Down syndrome, particularly those with congenital heart defects, to SARS-CoV-2 infection. By utilizing patient-specific induced pluripotent stem cells (iPSCs), the study aims to explore the biological mechanisms that contribute to the increased risk of severe COVID-19 outcomes in this population. The approach involves creating cellular models that mimic the genetic and physiological characteristics of these patients, allowing for a deeper understanding of their response to the virus. This research could lead to targeted therapies and preventive measures tailored for individuals with Down syndrome.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with Down syndrome, especially those who also have congenital heart defects.
Not a fit: Patients without Down syndrome or congenital heart defects may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies and better health outcomes for patients with Down syndrome who are at risk for severe COVID-19.
How similar studies have performed: While research on COVID-19 and its effects on various populations is ongoing, this specific approach using patient-specific iPSCs in the context of Down syndrome is relatively novel.
Where this research is happening
COLUMBUS, UNITED STATES
- RESEARCH INST NATIONWIDE CHILDREN'S HOSP — COLUMBUS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ZHAO, MINGTAO — RESEARCH INST NATIONWIDE CHILDREN'S HOSP
- Study coordinator: ZHAO, MINGTAO
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.